SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-432329
Filing Date
2013-11-07
Accepted
2013-11-07 13:13:49
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d599496d10q.htm 10-Q 446870
2 EX-31.1 d599496dex311.htm EX-31.1 9295
3 EX-31.2 d599496dex312.htm EX-31.2 9126
4 EX-32.1 d599496dex321.htm EX-32.1 3693
5 EX-32.2 d599496dex322.htm EX-32.2 3626
  Complete submission text file 0001193125-13-432329.txt   5069533

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT qlti-20130930.xml EX-101.INS 776956
7 XBRL TAXONOMY EXTENSION SCHEMA qlti-20130930.xsd EX-101.SCH 50966
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qlti-20130930_cal.xml EX-101.CAL 66915
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qlti-20130930_def.xml EX-101.DEF 159733
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE qlti-20130930_lab.xml EX-101.LAB 373735
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qlti-20130930_pre.xml EX-101.PRE 284327
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
QLT INC/BC (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17082 | Film No.: 131199670
SIC: 2834 Pharmaceutical Preparations